Key result
SHP-2 inhibition reverses methylglyoxal-induced monocyte VEGF resistance and dysfunction in diabetic models.
Answers are grounded in this paper and cite their sources.
Diabetes mellitus (DM) is a major cardiovascular risk factor contributing to cardiovascular complications by inducing vascular cell dysfunction. Monocyte dysfunction could contribute to impaired arteriogenesis response in DM patients. DM monocytes show blunted chemotactic responses to arteriogenic stimuli, a condition termed as vascular endothelial growth factor (VEGF) resistance. We hypothesize that methylglyoxal (MG), a glucose metabolite, induces monocyte dysfunction and aimed to elucidate the underlying molecular mechanisms. Human monocytes exposed to MG or monocytes from DM patients or mice (db/db) showed VEGF-resistance secondary to a pro-migratory phenotype. Mechanistically, DM conditions or MG exposure resulted in the upregulation of the expression of SHP-2 phosphatase. This led to the enhanced activity of SHP-2 and aided an interaction with SRC kinase. SHP-2 dephosphorylated the inhibitory phosphorylation site of SRC leading to its abnormal activation and phosphorylation of cytoskeletal protein, paxillin. We demonstrated that MG-induced molecular changes could be reversed by pharmacological inhibitors of SHP-2 and SRC and by genetic depletion of SHP-2. Finally, a SHP-2 inhibitor completely reversed the dysfunction of monocytes isolated from DM patients and db/db mice. In conclusion, we identified SHP-2 as a hitherto unknown target for improving monocyte function in diabetes. This opens novel perspectives for treating diabetic complications associated with impaired monocyte function.
No takes yet. Share an insight, caveat, or question.
Dorenkamp et al. (2018) studied Diabetes mellitus. Pharmacological inhibitors of SHP-2 and SRC, genetic depletion of SHP-2, and methylglyoxal exposure was evaluated on Monocyte VEGF resistance and chemotactic dysfunction via SHP-2/SRC kinase signalling. Pharmacological SHP-2 inhibition and genetic depletion reversed methylglyoxal-induced VEGF resistance and dysfunction in monocytes from diabetic patients and db/db mice.
Synapse has enriched 10 related papers. Consider them for comparative context: